Abstract:Background and Aims: The prognosis of hepatocellular carcinoma (HCC) treated with hepatic resection may be improved by the adjunctive use of transarterial chemoembolization (TACE). This study aimed to systematically compare the outcomes between hepatic resection with and without TACE groups. Methods: All relevant randomized controlled trials (RCTs) and non-RCTs were searched by the PubMed, EMBASE, and Cochrane Library databases. Overall survival (OS) and disease-free survival (DFS) were two major outcomes. Meta-analyses were performed according to the timing of TACE (pre- or post-operative TACE). Subgroup analyses were also performed. Hazard ratios (HRs) with 95% confidence intervals (95%CIs) were calculated. Results: Overall, 55 papers were included (14 RCTs and 41 non-RCTs). Overall meta-analyses demonstrated that OS and DFS were statistically similar between hepatic resection with and without pre-operative TACE groups (HR = 1.01, 95%CI = 0.87-1.19, P = 0.87; HR = 0.91, 95%CI = 0.82-1.01, P = 0.07). Subgroup analyses of RCTs or non-RCTs showed that OS and DFS remained statistically similar between hepatic resection with and without pre-operative TACE groups. Subgroup analysis of incomplete or no tumor necrosis showed that OS was worse in hepatic resection with pre-operative TACE group than in hepatic resection without pre-operative TACE group. By contrast, subgroup analysis of complete tumor necrosis showed that DFS was better in hepatic resection with pre-operative TACE group than in hepatic resection without pre-operative TACE group. Overall meta-analyses demonstrated that OS and DFS were better in hepatic resection with post-operative TACE group than in hepatic resection without postoperative TACE group (HR = 0.85, 95%CI = 0.72-1.00, P = 0.06; HR = 0.83, 95%CI = 0.73-0.94, P = 0.004). Subgroup analyses of RCTs, vascular invasion, or large HCC showed that OS and DFS remained better in hepatic resection with postoperative TACE group than in hepatic resection without post-operative TACE group. By contrast, subgroup analyses of non-RCTs, no vascular invasion, or small HCC showed that OS and DFS were statistically similar between the two groups. Conclusions: Post-operative TACE, rather than pre-operative TACE, may be considered as an adjunctive treatment option for HCC treated with hepatic resection.

Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta‐analysis.

Influence of Preoperative Transarterial Chemoembolization on Patients' Perioperative Safety and Short-Term Prognosis after Liver Transplantation

Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis

Preoperative Transarterial Chemoembolization for Resectable Hepatocellular Carcinoma in Asia Area: A Meta-Analysis of Random Controlled Trials

Arterial Chemoembolization Before Liver Transplantation in Patients with Hepatocellular Carcinoma: Marked Tumor Necrosis, but No Survival Benefit?

Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: a Single Center Analysis.

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma

A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Preoperative Transarterial Chemoembolization Does Not Increase Hepatic Artery Complications after Liver Transplantation: A Single Center 12-Year Experience.

Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses

Influence of Preoperative Transcatheter Arterial Chemoembolization on Liver Resection in Patients with Resectable Hepatocellular Carcinoma.

Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis

Meta analysis of transcatheter arterial chemoembolization before hepatectomy for primary hepatocellular carcinoma

Effect of Preoperative Transcatheter Arterial Chemoembolization for Treatment of Resectable Large Hepatocellular Carcinoma:A Clinical Randomized Controlled Trial

Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis.

Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-term Survival and Recurrence in Patients with Resectable Huge Hepatocelluar Carcinoma A Multicentre Retrospective Analysis

Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for the management of patients with hepatocellular carcinoma: a systematic review and meta-analysis

Effect of Preoperative Chemoembolization for Resectable Hepatocellular Carcinoma with Portal Vein Invasion:A Prospective Non-Random Study

Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma

Effect of preoperative adjuvant transcatheter hepatic arterial chemoembolization on prognosis of resectable huge hepatocellular carcinoma

Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis